Fewer PSA Tests May Cut Overdiagnosis But Miss Aggressive Prostate Cancer Cases
The incidence of more aggressive prostate cancer cases that are higher-grade disease and metastasis at diagnosis have risen.
Read MorePosted by Chris Wolski | Apr 29, 2022 | Prostate |
The incidence of more aggressive prostate cancer cases that are higher-grade disease and metastasis at diagnosis have risen.
Read MorePosted by Andy Lundin | Apr 18, 2022 | Heart Disease |
About one in four adults has a liver disorder that is a risk factor for heart disease, according to the American Heart Association.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Molecular Diagnostics |
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read MorePosted by Chris Wolski | Nov 24, 2021 | Diabetes & Metabolic Diseases |
Siemens Healthineer’s ELF Test performed the best of the five blood biomarkers selected for the FNIH NIMBLE Study.
Read MorePosted by Chris Wolski | Oct 22, 2021 | Diabetes & Metabolic Diseases |
New research creates a road map for future treatments of nonalcoholic fatty liver disease and confirms the need for more mainstream screening.
Read More